CLOs on the Move


 
At Vyaire, we know that each patient has different goals—and every breath counts to achieve them. We are a company on the move, relentlessly innovating, challenging the status quo and keeping patient needs at the forefront of everything we do to enable, enhance and extend lives. Established from legacy brands with a 65-year history of pioneering breathing technology, Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. We pledge to evolve what`s possible to ensure every breath is taken to its fullest. We accomplish this through our values: One Voice, Patient Purpose, ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.vyaire.com
  • 26125 North Riverwoods Boulevard
    Mettawa, IL USA 60045
  • Phone: 833.327.3284

Executives

Name Title Contact Details
Rachel Lisenby
Associate General Counsel, Corporate Profile
Cally Kothmann
Associate General Counsel Profile
John Bibb
Group Chief Executive Officer Profile

Similar Companies

Primus Sterilizer

Primus Sterilizer is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Product Insight

Product Insight, Inc. is a Acton, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Respicardia

Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.

Lakeshore Biomaterials Inc

Lakeshore Biomaterials Inc is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Still River Systems, Inc.

Still River Systems is dedicated to providing physicians and their patients access to high quality, cost-effective proton therapy solutions, and to helping establish this superior treatment modality as a standard of care for patients worldwide.